1327. SUBSTITUTION OF DOSAGE FORMS

1327 SUBSTITUTION OF DOSAGE FORMS 1327.1 A pharmacist may dispense a dosage form of a drug product different from that prescribed, such as a tablet instead of a capsule or liquid instead of tablets, provided that: The pharmacist notifies the patient of the dosage form substitution prior to filling the prescription; The pharmacist documents the substitution on the prescription record; The pharmacist notifies the practitioner of the dosage form substitution prior to dispensing or as soon as is reasonably possible thereafter; and The dosage form dispensed contains the identical amount of the active ingredients as the dosage prescribed for the patients, is not an enteric-coated or time release product; and does not alter desired clinical outcomes. 1327.2 The notification required in § 1327.1(c) shall not apply to those circumstances where the dosage form substitution is made in order to comply with the prescriber’s intent, (i.e., physician prescribed tablets but the medication only comes in capsules.) 1327.3 Substitution of dosage form shall not include the substitution of a product that has been compounded by the pharmacist unless the pharmacist contacts the practitioner prior to dispensing and obtains permission to dispense the compounded product. SOURCE: Final Rulemaking published at 56 DCR 4742 (June 19, 2009). District of Columbia Municipal Regulations Public Health and Medicine 22-B DCMR § 1327